Richard Lee

9.2k total citations · 3 hit papers
75 papers, 5.1k citations indexed

About

Richard Lee is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Richard Lee has authored 75 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 25 papers in Surgery and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Richard Lee's work include Cholesterol and Lipid Metabolism (16 papers), Lipid metabolism and disorders (13 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). Richard Lee is often cited by papers focused on Cholesterol and Lipid Metabolism (16 papers), Lipid metabolism and disorders (13 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). Richard Lee collaborates with scholars based in United States, Canada and Germany. Richard Lee's co-authors include Mark J. Graham, Rosanne M. Crooke, Lawrence L. Rudel, Thomas Q. de Aguiar Vallim, Aldons J. Lusis, Peter A. Edwards, Zeneng Wang, Stanley L. Hazen, Diana M. Shih and Brian J. Bennett and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Richard Lee

75 papers receiving 5.0k citations

Hit Papers

Trimethylamine-N-Oxide, a Metabolite Associated with Athe... 2013 2026 2017 2021 2013 2017 2022 250 500 750

Peers

Richard Lee
Marcelo Amar United States
Murielle M. Véniant United States
Renee Leboeuf United States
Yi Zhu China
Xiong Z. Ruan United Kingdom
Uwe J.F. Tietge Netherlands
Richard Lee
Citations per year, relative to Richard Lee Richard Lee (= 1×) peers Lawrence W. Castellani

Countries citing papers authored by Richard Lee

Since Specialization
Citations

This map shows the geographic impact of Richard Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Lee more than expected).

Fields of papers citing papers by Richard Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Lee. The network helps show where Richard Lee may publish in the future.

Co-authorship network of co-authors of Richard Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Lee. A scholar is included among the top collaborators of Richard Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Lee. Richard Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rohde, Ellen, Richard Lee, Anne Marie Mazzola, et al.. (2025). † VERVE-102, a clinical stage in vivo base editing medicine, leads to potent and precise inactivation of PCSK9 in preclinical studies. Journal of clinical lipidology. 19(3). e68–e68. 1 indexed citations
2.
Rasheed, Adil, Sabrina Robichaud, My-Anh Nguyen, et al.. (2024). Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche. Nature Cardiovascular Research. 3(5). 594–611. 2 indexed citations
3.
Murray, Sue, Richard Lee, Audrey Low, et al.. (2024). LipidSIM: Inferring mechanistic lipid biosynthesis perturbations from lipidomics with a flexible, low-parameter, Markov modeling framework. Metabolic Engineering. 82. 110–122. 2 indexed citations
4.
Tian, Ye, Kritika Mehta, Wei Lu, et al.. (2023). Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis. Hepatology. 79(4). 882–897. 20 indexed citations
5.
Tian, Ye, et al.. (2023). Targeting phospholipid remodeling pathway improves insulin resistance in diabetic mouse models. The FASEB Journal. 37(11). e23251–e23251. 4 indexed citations
6.
Ramms, Bastian, Xiaoli Sun, Ariane Pessentheiner, et al.. (2022). Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering. JCI Insight. 7(13). 16 indexed citations
7.
Ericson, Elke, Anne‐Christine Andréasson, Carly I. Dix, et al.. (2022). Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans. Hepatology Communications. 6(10). 2689–2701. 14 indexed citations
8.
Singh, Abhishek K., Balkrishna Chaube, Xinbo Zhang, et al.. (2021). Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice. Journal of Clinical Investigation. 131(17). 75 indexed citations
9.
Goedeke, Leigh, Alberto Canfrán‐Duque, Noemí Rotllán, et al.. (2021). MMAB promotes negative feedback control of cholesterol homeostasis. Nature Communications. 12(1). 6448–6448. 16 indexed citations
10.
Lang, Jennifer M., Lei Cai, Zhen Wang, et al.. (2021). Dietary and Pharmacologic Manipulations of Host Lipids and Their Interaction With the Gut Microbiome in Non-human Primates. Frontiers in Medicine. 8. 646710–646710. 7 indexed citations
11.
Attie, Alan, Mark P. Keller, Kelly A. Mitok, et al.. (2021). Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy. Laboratory Investigation. 101(7). 935–941. 12 indexed citations
14.
Lee, Richard, et al.. (2018). Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr–/– mice. Atherosclerosis. 275. 43–49. 8 indexed citations
15.
Rajbhandari, Prashant, Brandon J. Thomas, Cynthia Hong, et al.. (2017). IL-10 Signaling Remodels Adipose Chromatin Architecture to Limit Thermogenesis and Energy Expenditure. Cell. 172(1-2). 218–233.e17. 143 indexed citations
16.
Graham, Mark J., Richard Lee, Teresa Brandt, et al.. (2017). Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides. New England Journal of Medicine. 377(3). 222–232. 454 indexed citations breakdown →
17.
Lee, Richard, Wuxia Fu, Mark J. Graham, et al.. (2012). Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein. Journal of Lipid Research. 54(3). 602–614. 31 indexed citations
18.
Brown, J. Mark, Jenna L. Betters, Caleb C. Lord, et al.. (2010). CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. Journal of Lipid Research. 51(11). 3306–3315. 125 indexed citations
19.
Lee, Richard & Jonathan Z. Baskin. (2006). Improving outcomes of locoregional flaps: an emphasis on anatomy and basic science. Current Opinion in Otolaryngology & Head & Neck Surgery. 14(4). 260–264. 14 indexed citations
20.
Rudel, Lawrence L., et al.. (2001). Acyl coenzyme A : cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Current Opinion in Lipidology. 12(2). 121–127. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026